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Young womanAcute abdomen secondary to ovarian carcinoma is rare, especially in a young woman. A 28-year-old obese
woman underwent bilateral salpingo-oophorectomy and omentectomy as emergency surgery. The spec-
imen from the right ovarian adenocarcinoma was fragmented because the tumor had disintegrated. The
largest fragment measured 14 × 8 × 2.5 cm. The left ovary had a solid adenocarcinomatous tumor measur-
ing 6 × 5 × 3 cm. In addition, there were disseminated lesions in the greater omentum, peritoneum, pouch
of Douglas and the serosal surface of the uterus. Microscopically, the specimen was a Grade 3 poorly dif-
ferentiated ovarian endometrioid adenocarcinoma with focal cyst-like structures. Several moderately di-
lated follicular cysts were seen in addition to the adenocarcinomas but no deﬁnite endometriosis was
identiﬁed in the noncancerous areas of the bilateral ovaries. The endometrium was atrophic and there
was endometriosis in the serosa of the uterus, which was resected 3months later during a second-look op-
eration. These observations suggest that the acute abdomen in this case was caused by disintegration and
bleeding right ovarian cancer. The risk factors for ovarian endometrioid adenocarcinoma in this case
might have been obesity and possibly endometriosis., Kitasato
awa 252
ahashi).
his is an2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ovarian carcinomapresenting as acute abdomen is rare, especially in
a young woman. The main cause of acute abdomen in patients with an
ovarian tumor was noted to be adnexal torsion [1], rupture of cystic
components [2–9] and bleeding from the tumor [3–5,7,9,10]. The rate
of torsion in malignant ovarian neoplasm was 1.1% [1]. Some cases of
rupture secondary to a malignant ovarian neoplasm were reported
[6–9]. That torsionwould cause bleeding from amalignant ovarian neo-
plasm was noted in one case report [10]. Rupture of cystic components
of a malignant ovarian tumor that caused hemorrhage was the topic of
reports of 5 cases similar to our case [3–5,7,9]. However, those patients
(mean age: 53.6 years, range: 40–76) were much older than our case.
Here we report, to the best of our knowledge, the ﬁrst ovarian
endometrioid adenocarcinoma presenting as an acute abdomen in a
young woman. We discuss the histopathological ﬁndings suggesting
the cause of the acute abdomen and risk factors for carcinogenesis in
this young woman.University School of
-0374, Japan.
open access article under th2. Clinical summary
The patient was a 28-year-old obese womanwith no family histo-
ry of cancer, height 158 cm, weight 79 kg (body mass index: BMI
31.65 kg/m2), gravida 0, para 0. She had sudden onset of abdominal
pain and visited a local emergency hospital. A computed tomography
(CT) scan revealed a huge solid and multicystic intraabdominal and
hemorrhagic mass and ascites (Fig. 1). She was transferred to Kitasato
University Hospital because of suspicion of ovarian rupture. In the am-
bulance, her systolic blood pressure temporarily decreased to approxi-
mately 60 mm Hg. When she arrived at Kitasato University Hospital,
her consciousness was clear, blood pressure was 150/70 mm Hg,
and pulse was 110 bpm. Laboratory examination revealed WBC of
16.3 × 103/μl, RBC of 3.16 × 106/μl, hemoglobin (Hb) of 5.1 mg/dl, and
CRP of 7.17 mg. An intraabdominal high echoic mass was shown by ul-
trasound examination. Abdominal pain and abdominal distension
worsened gradually over the next 2 days. She had progressive anemia
and hypotension, and was diagnosed as having a ruptured ovarian
tumor. She underwent an emergency operation. Initially, clinicians
thought that the tumorwas benign considering her age, and before sur-
gery had planned partial resection of the ovary. Since intraoperative
ﬁndings implied a malignant neoplasm, they changed the operative
procedure to a bilateral salpingo-oophorectomy, omentectomy ande CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Abdominal computed tomography (CT). CT scan revealed a huge solid andmulticystic
intraabdominal hemorrhagic mass and ascites.
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an explanation of the alteration in plans and obtaining their agree-
ment. Intraoperative ﬁndings showed prominent intraabdominal
hemorrhage, enlarged right ovary with capsule rupture, and a
disintegrated tumor of the right ovary. Intraoperative bleeding mea-
sured 3710 ml and there was adhesion between the ovarian tumor
and sigmoid colon.Fig. 2.Macroscopic ﬁndings for the ovarian tumors. (A) Multiple fragments of the right ovarian
area 6 × 5 × 3 cm (left) with paraovarian connective tissue containing a thin-walled cystic lesio
adipose tissue measuring 18 × 14 × 2.5 cm and 11 × 6 × 1 cm, respectively, within which wer
(indicated by arrows).3. Pathological ﬁndings
Macroscopically, the right ovarian tumor was excised in multi-
ple fragments due to disintegration, with the largest fragment being
14 × 8 × 2.5 cm (Fig. 2A). On cut surfaces, grayish- or yellowish-white
solid components with several focal red–brown areas were observed.
It was not clear where fragments had adhered to the sigmoid colon.
The left ovary had a solid areameasuring 6 × 5 × 3 cm,withmacroscopic
ﬁndings similar to the right ovarian tumor (ﬁgure, left) with para-
ovarian connective tissue containing a thin-walled cystic lesion measuring
8 × 4.5 cm (ﬁgure, right) (Fig. 2B). The greater omentum had two nodules,
with the largest dimensions being 3 cm and 2 cm, respectively (Fig. 2C). In
addition, there were disseminated lesions in the mesentery, peritoneum,
pouch of Douglas and serosal surface of the uterus.
Microscopically, the tumor had solid areas (Fig. 3A) with focal tubu-
lar glands and also cribriform (Fig. 3B) and villoglandular patterns
(Fig. 3C) composed of atypical epithelia without mucin accompanied
by massive necrosis. A few bizarre nuclei were seen, particularly in the
solid growth area (Fig. 3D). The bilateral ovarian cancer predominantly
consisted of solid proliferation, but cyst-like structures, lined by tumor
cells, were also evident (Fig. 3E and F). In the non-cancerous areas of
the bilateral ovaries within each of 10 microscope slides made, there
were no chocolate cysts but focally several moderately dilated follicular
cysts were evident (Fig. 4A and B).
Immunohistochemically, tumor cells were positive for AE1/AE3,
vimentin, ER, PgR and p53 and were negative for WT-1 and HNF1β
(Fig. 5). MIB-1 LI value was high (N90%) (Fig. 5). Based on the above
pathological ﬁndings, the diagnosis was ovarian endometrioid adeno-
carcinoma, Grade 3, FIGO stage IIIc.
Atrophic endometrium and endometriosis can be seen in the serosa
of the uterus, (Fig. 4C).tumor, with the largest 14 × 8 × 2.5 cm (upper-left half). (B) Left ovary contained a solid
n measuring 8 × 4.5 cm (right). (C) Two fragments of the greater omentum consisting of
e two nodular lesions measuring 3 cm and 2 cm, respectively, at their greatest dimension
Fig. 3.Microscopicﬁndings for the ovarian tumor. (A) Solid growth, (B) tubular glands and cribriform, (C) and villoglandular pattern. (D) Focal bizarre nuclei in the solid growth area. Cyst-
like structures that were lined by cancer cells in the bilateral ovarian tumor. (E) Right ovary. (F) Left ovary. Original magniﬁcation: (A), (B) and (C) ×200; (D) ×400; (E) and (F) ×20.
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The rupture ofmalignant ovarian tumors has been rare, but there have
been case reports of rupture of ovarian tumors, such as granular cell
tumors [2–5], clear cell adenocarcinoma [6], serous cystadenocarcinoma
[7], mucinous cyst adenocarcinoma [8], and malignant mixed mesoder-
mal tumor [9]. Most cases were associated with cystic lesions except for
two cases of granulosa cell tumors for which there were no details of
macroscopic ﬁndings. One case report stated that bleeding from ovarian
cancer might be caused by adnexal torsion [10].
Our patient had intraabdominal hemorrhage, with bleeding from
the disintegrated right ovarian tumor, fragmentation of right ovarian
tumor because of disintegration, leading to shock before surgery.
Taken together, these ﬁndings might indicate that not only rupture of
the cystic component but also that disintegration of the ovarian tumor
might have resulted in hemorrhage and acute abdomen. However, it isFig. 4.Microscopic ﬁndings of the background tissue. Several moderately dilated follicular cyst
ovary. (C) Uterus. Original magniﬁcation: ×40; inset ×400.difﬁcult to deny the possibility that endometriosis might have been as-
sociated with the hemorrhage.
The highest incidence of ovarian carcinoma is in the 40–49 age
group, with only 3.6% occurring in the 15–29 age group [11]. Acute ab-
domen secondary to rupture of the cystic component in ovarian cancer
has only been reported to occur in women 40 years of age or older
[3–5,7,9]. It was difﬁcult to determine the cause of carcinogenesis in
our case because little is known about the etiology of ovarian cancer.
In endometrial cancer, polycystic ovary syndrome (PCOS) or obesity
may increase the risk of carcinogenesis [12,13]. PCOS is a common en-
docrine disorder in women of reproductive age. Features of PCOS in-
clude menstrual irregularity, multiple ovarian follicular cysts, elevated
serum testosterone or androstenedione, etc. [14–17]. In peripheral adi-
pose tissues of obese women, androgens change to estrogens, which
stimulate proliferation of the endometrium [13]. This patient was over-
weight and had several multiple moderately dilated follicular cysts ins in the ovaries and endometriosis in the serosal region of uterus. (A) Right ovary. (B) Left
Fig. 5. Immunohistochemical ﬁndings for the ovarian tumor. Note the strong immunoreactivity for AE1/AE3, vimentin, PgR, p53, a high MIB-1 labeling index (N90%) and weak immuno-
reactivity for ER and were negative for WT-1 and HNF1β. Original magniﬁcation: ×400.
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menstruation. Therefore it was suggested that she might not have
PCOS. Endometriosis was thought to be one of the causes of her dys-
menorrhea, because she had endometriosis in the serosa of the uterus.
Endometriosis is an estrogen-dependent disease, and there have been
reports of an increased risk of ovarian endometrioid and clear cell carci-
nomas in women with endometriosis [18–22]. Studies have suggested
that a high estrogen status might be associated with the malignant
transformation of endometriosis [23,24]. This patient's carcinoma was
ER positive and might have been sensitive to estrogen. Possibly the
risk of ovarian cancer in this case would have been increased because
hyperestrogenism due to obesitymight have stimulated endometriosis.
In conclusion, we report a rare case of an ovarian cancer presenting
as acute abdomen and, to the best of our knowledge, this is the ﬁrst case
of endometrioid adenocarcinoma in a youngwoman. The cause of acute
abdomen was possibly the rupture of the ovarian tumor and hemor-
rhage was due to its disintegration. Her ovarian carcinogenesis might
be associated with endometriosis and obesity.References
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